Nux Moschata Globule 1dh-30ch 1 Dh Tablet is a Health Canada–registered human drug (DIN 00682543) held by Boiron Laboratoires, containing Nux Moschata. Health Canada lists its status as Cancelled Post Market (status date 16 Feb 1998). Nexara Health has matched 9 registrations of Nux Moschata across 1 other regulated market.
Health Canada registration
| DIN | 00682543 |
|---|---|
| Brand name | Nux Moschata Globule 1dh-30ch |
| Active ingredient | Nux Moschata |
| Strength | 1 Dh |
| Dosage form | Tablet |
| Route | Oral |
| Company | Boiron Laboratoires |
| Status | Cancelled Post Market — 16 Feb 1998 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Nux Moschata registered in other markets
9 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nux Moschata | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Nux Moschata worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Nux Moschata Globule 1dh-30ch (DIN 00682543) marketed in Canada?
No. Health Canada lists DIN 00682543 as Cancelled Post Market as of 16 Feb 1998.
Who holds the Canadian licence for this product?
Boiron Laboratoires is the company of record in the Health Canada Drug Product Database.
Is Nux Moschata registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00682543, status date 1998-02-16; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00682543, status date 1998-02-16; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00682543, status date 1998-02-16; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.